Moderna expects to break even in 2026, says CEO Stéphane Bancel
HQ Team January 5, 2023: Moderna Inc., expects to break even in 2026 as it aims to drive profits by “disciplined investment” and.
Drugs
Health
Pharma
Drugs
Medical
Pharma
Zevra Therapeutics completes acquisition of Acer in a $91m deal
HQ Team November 21, 2023: Zevra Therapeutics, Inc. has finalized its acquisition of Acer Therapeutics Inc in a $91m deal. This strategic acquisition.
Drugs
Health
Pharma
AstraZeneca inks $245 million deal with Cellectis for rare diseases
HQ Team November 1, 2023: AstraZeneca signed a $245 million deal with a French clinical-stage biotechnology firm, Cellectis, to speed up therapeutics in.
Drugs
Health
Pharma
Amgen completes $27.8b acquisition of Horizon Therapeutics
Amgen Inc., a US biotechnology company, completed the acquisition of Horizon Therapeutics Plc for $27.8 billion, gaining access to the Dublin-based firm’s two.
Drugs
Health
Pharma
FDA plans project to aid companies in making drugs for rare diseases
HQ Team October 4, 2023: The FDA is planning a pilot program to accelerate the development of drugs and biological products for rare.
Drugs
Health
Pharma
India fully exempts import tax for drugs treating rare diseases
India has granted a complete customs duty exemption for the personal use of medicines to treat rare diseases, including Merc & Co’s Keytruda.
Drugs
Pharma
Moderna in $35 million licensing deal with CytomX
Moderna, a US-based biotechnology company, announced a $35 million licensing deal with cancer-focused drugmaker CytomX to develop messenger RNA therapies.
Drugs
Pharma
Amgen to buy Dublin-based Horizon for $27.8 billion
Amgen Inc, one of the world's largest biotechnology companies, will acquire Dublin-based Horizon Therapeutics Plc for $27.8 billion.